Pure Global

PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL CITOMEGALOVIRUS (CMV) - COFEPRIS Registration 0086R2024 SSA

Access comprehensive regulatory information for PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL CITOMEGALOVIRUS (CMV) (PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL CITOMEGALOVIRUS (CMV)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 0086R2024 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on January 11, 2024.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
0086R2024 SSA
PRUEBA DE AMPLIFICACIÓN DE ÁCIDOS NUCLEICOS IN VITRO PARA LA CUANTIFICACIÓN DEL ADN DEL CITOMEGALOVIRUS (CMV)
COFEPRIS Analysis ID: 0086R2024 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
COBAS® CMV ROCHE
Trade Name (English)
COBAS® CMV ROCHE
Registration Information
Analysis ID
0086R2024 SSA
Registration Date
January 11, 2024
Manufacturer / Fabricante
Name (English)
PRODUCTOS ROCHE, S.A. DE C.V.